Characterization of the Selective in Vitro and in Vivo Binding Properties of Crenezumab to Oligomeric Aβ
Alzheimer's Research and Therapy - United Kingdom
doi 10.1186/s13195-019-0553-5
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2019
Authors
Publisher
Springer Science and Business Media LLC